A new AI tool developed by Mass General Brigham has identified long COVID in 22.8% of patients, much higher than previous 7% estimates. The tool analyses health records from nearly 300,000 patients, using 'precision phenotyping' to distinguish long COVID symptoms from pre-existing conditions. It improves diagnostic accuracy and addresses demographic biases. Researchers plan to release the algorithm publicly for global use, potentially advancing research on long COVID subtypes.
HKUST has developed AI medical models to assist with cancer and disease diagnosis. 'MedDr', a medical ChatGPT-like tool, generates reports from images. 'MOME' focuses on breast cancer, analysing MRIs with over 90% accuracy. These tools could reduce diagnosis time by 40%. HKUST plans to collaborate with hospitals and aims to establish a new medical school with AI-integrated healthcare.
